Increasing evidence has demonstrated that many miRNAs play important roles in COVID-19 and lung cancer progression via NF-κB-related pathways (118, 119), serving as potential diagnostic markers, prognostic markers, and therapeutic targets. The gene discussed is NFKB1; the disease is lung cancer.